-
1
Head and neck cancers exhibit diverse biological characteristics, impacting patient quality of life despite advances in treatment.
-
2
Personalized medicine is transforming head and neck cancer care through molecularly informed strategies for prevention, diagnosis, and treatment.
-
3
Innovative therapies, including immune checkpoint inhibitors and targeted agents, are expanding treatment options while aiming to reduce toxicity.
-
4
Osteoradionecrosis presents unique challenges, requiring tailored perioperative planning and long-term multidisciplinary support for better outcomes.
-
5
Risk-adapted strategies in adjuvant therapy can optimize treatment for oral squamous cell carcinoma, minimizing toxicity for low-risk patients.
